| RNA | 表記: | 4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE | 組成式: | C16 H14 N2 O4 S2 | SMILES: | O=C1N=C(S/C1=Cc2oc(cc2)C)NS(=O)(=O)c3ccc(cc3)C | InChi: | InChI=1S/C16H14N2O4S2/c1-10-3-7-13(8-4-10)24(20,21)18-16-17-15(19)14(23-16)9-12-6-5-11(2)22-12/h3-9H,1-2H3,(H,17,18,19)/b14-9- | 別名: | (Z)-4-METHYL-N-(5-((5-METHYLFURAN-2-YL)METHYLENE)-4-OXO-4,5-DIHYDROTHIAZOL-2-YL)BENZENESULFONAMIDE | 定義日: | 2006-08-02 | 最終更新日: | 2020-06-17 | 識別子(ID): | 4-methyl-N-{(5Z)-5-[(5-methylfuran-2-yl)methylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}benzenesulfonamide |
|
| RNB | 表記: | 3-chloro-5-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-4,6-dihydroxy-2-methylbenzaldehyde | 組成式: | C18 H23 Cl O3 | SMILES: | Clc1c(c(c(O)c(c1O)CC=C(/C)CCC=C(/C)C)C=O)C | InChi: | InChI=1S/C18H23ClO3/c1-11(2)6-5-7-12(3)8-9-14-17(21)15(10-20)13(4)16(19)18(14)22/h6,8,10,21-22H,5,7,9H2,1-4H3/b12-8+ | 別名: | Colletochlorin B | 定義日: | 2013-01-31 | 最終更新日: | 2020-06-17 | 公開日: | 2013-03-13 | 識別子(ID): | 3-chloro-5-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-4,6-dihydroxy-2-methylbenzaldehyde |
|
| 5ID | 表記: | (2R,3R,4S,5R)-2-(4-AMINO-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL | 組成式: | C11 H13 I N4 O4 | SMILES: | Ic2c1c(ncnc1n(c2)C3OC(C(O)C3O)CO)N | InChi: | InChI=1S/C11H13IN4O4/c12-4-1-16(10-6(4)9(13)14-3-15-10)11-8(19)7(18)5(2-17)20-11/h1,3,5,7-8,11,17-19H,2H2,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1 | 別名: | 5-IODOTUBERCIDIN | 定義日: | 2005-10-16 | 最終更新日: | 2020-06-17 | 識別子(ID): | 5-iodo-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
| RNO | 表記: | (R)-PARA-NITROSTYRENE OXIDE | 組成式: | C8 H7 N O3 | SMILES: | [O-][N+](=O)c1ccc(cc1)C2OC2 | InChi: | InChI=1S/C8H7NO3/c10-9(11)7-3-1-6(2-4-7)8-5-12-8/h1-4,8H,5H2/t8-/m0/s1 | 別名: | (2R)-2-(4-NITROPHENYL)OXIRANE | 定義日: | 2005-05-20 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2R)-2-(4-nitrophenyl)oxirane |
|
| RNR | 表記: | 3,6-bis(3-(3'-(R)-fluoropyrrolindino)propionamido)acridine | 組成式: | C27 H31 F2 N5 O2 | SMILES: | O=C(Nc4cc3nc2cc(NC(=O)CCN1CCC(F)C1)ccc2cc3cc4)CCN5CCC(F)C5 | InChi: | InChI=1S/C27H31F2N5O2/c28-20-5-9-33(16-20)11-7-26(35)30-22-3-1-18-13-19-2-4-23(15-25(19)32-24(18)14-22)31-27(36)8-12-34-10-6-21(29)17-34/h1-4,13-15,20-21H,5-12,16-17H2,(H,30,35)(H,31,36)/t20-,21-/m1/s1 | 別名: | N,N'-acridine-3,6-diylbis{3-[(3R)-3-fluoropyrrolidin-1-yl]propanamide} | 定義日: | 2010-07-27 | 最終更新日: | 2020-06-17 | 識別子(ID): | N,N'-acridine-3,6-diylbis{3-[(3R)-3-fluoropyrrolidin-1-yl]propanamide} |
|
| RO2 | 表記: | 3-[5-[5-(4-METHYL-PIPERAZIN-1-YL)-1H-IMIDAZO[4,5-B]PYRIDIN-2-YL]-BENZIMIDAZOL-2-YL]-PHENOL | 組成式: | C24 H23 N7 O | SMILES: | n2c(N1CCN(C)CC1)ccc3nc(nc23)c6ccc5nc(c4cccc(O)c4)nc5c6 | InChi: | InChI=1S/C24H23N7O/c1-30-9-11-31(12-10-30)21-8-7-19-24(28-21)29-23(26-19)16-5-6-18-20(14-16)27-22(25-18)15-3-2-4-17(32)13-15/h2-8,13-14,32H,9-12H2,1H3,(H,25,27)(H,26,28,29) | 別名: | META-OH(N) HOECHST | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-{6-[5-(4-methylpiperazin-1-yl)-1H-imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-yl}phenol |
|
| RO8 | 表記: | N-{[(2Z)-5-bromo-1,3-thiazol-2(3H)-ylidene]carbamoyl}-3-chlorobenzenesulfonamide | 組成式: | C10 H7 Br Cl N3 O3 S2 | SMILES: | BrC=2S/C(=NC(=O)NS(=O)(=O)c1cccc(Cl)c1)NC=2 | InChi: | InChI=1S/C10H7BrClN3O3S2/c11-8-5-13-10(19-8)14-9(16)15-20(17,18)7-3-1-2-6(12)4-7/h1-5H,(H2,13,14,15,16) | 別名: | RO5062408 | 定義日: | 2011-01-17 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-{[(2Z)-5-bromo-1,3-thiazol-2(3H)-ylidene]carbamoyl}-3-chlorobenzenesulfonamide |
|
| ROA | 表記: | (2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid | 組成式: | C18 H16 O8 | SMILES: | O=C(O)C(OC(=O)C=Cc1ccc(O)c(O)c1)Cc2cc(O)c(O)cc2 | InChi: | InChI=1S/C18H16O8/c19-12-4-1-10(7-14(12)21)3-6-17(23)26-16(18(24)25)9-11-2-5-13(20)15(22)8-11/h1-8,16,19-22H,9H2,(H,24,25)/b6-3+/t16-/m1/s1 | 別名: | Rosmarinic acid | 定義日: | 2011-09-02 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid |
|
| ROL | 表記: | ROLIPRAM | 組成式: | C16 H21 N O3 | SMILES: | O=C3NCC(c2cc(OC1CCCC1)c(OC)cc2)C3 | InChi: | InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)/t12-/m0/s1 | 別名: | (4R)-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]-2-PYRROLIDINONE | 定義日: | 2001-08-01 | 最終更新日: | 2020-06-17 | 識別子(ID): | (4R)-4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one |
|
| ROV | 表記: | nevanimibe | 組成式: | C27 H39 N3 O | SMILES: | C(C)(C)c1c(c(C(C)C)ccc1)NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C | InChi: | InChI=1S/C27H39N3O/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31) | 別名: | N-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)-N'-[2,6-di(propan-2-yl)phenyl]urea | 定義日: | 2020-02-18 | 最終更新日: | 2020-06-17 | 公開日: | 2020-05-13 | 識別子(ID): | N-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)-N'-[2,6-di(propan-2-yl)phenyl]urea |
|
| RP1 | 表記: | 6-(6-AMINO-PURIN-9-YL)-2-THIOXO-TETRAHYDRO-2-FURO[3,2-D][1,3,2]DIOXAPHOSPHININE-2,7-DIOL | 組成式: | C10 H12 N5 O5 P S | SMILES: | S=P3(OCC4OC(n1c2ncnc(N)c2nc1)C(O)C4O3)O | InChi: | InChI=1S/C10H12N5O5PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(19-10)1-18-21(17,22)20-7/h2-4,6-7,10,16H,1H2,(H,17,22)(H2,11,12,13)/t4-,6-,7-,10-,21-/m1/s1 | 別名: | RP-ADENOSINE-3',5'-CYCLIC-MONOPHOSPHOROTHIOATE | 定義日: | 2002-12-13 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2R,4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-sulfide |
|
| RP2 | 表記: | (2R,4aR,6R,7R,7aS)-6-(6-amino-8-bromo-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol
2-sulfide | 組成式: | C10 H11 Br N5 O5 P S | SMILES: | Brc2nc1c(ncnc1n2C4OC3COP(=S)(OC3C4O)O)N | InChi: | InChI=1S/C10H11BrN5O5PS/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(20-9)1-19-22(18,23)21-6/h2-3,5-6,9,17H,1H2,(H,18,23)(H2,12,13,14)/t3-,5-,6-,9-,22-/m1/s1 | 別名: | 8-Bromoadenosine-3',5'-cyclic monophosphorothioate | 定義日: | 2010-11-21 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2R,4aR,6R,7R,7aS)-6-(6-amino-8-bromo-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-sulfide |
|
| 9KL | 表記: | (2S)-2-[3-(benzenecarbonyl)phenyl]propanoic acid | 組成式: | C16 H14 O3 | SMILES: | c1cc(C(C)C(=O)O)cc(c1)C(=O)c2ccccc2 | InChi: | InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m0/s1 | 別名: | Dexketoprofen | 定義日: | 2018-05-21 | 最終更新日: | 2020-06-17 | 公開日: | 2019-03-13 | 識別子(ID): | (2S)-2-[3-(benzenecarbonyl)phenyl]propanoic acid |
|
| 9KU | 表記: | 5-hydroxy-2-[(2S)-1-{[(naphthalen-1-yl)oxy]acetyl}pyrrolidin-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid | 組成式: | C21 H19 N3 O6 | SMILES: | C4(NC(C1CCCN1C(=O)COc3cccc2ccccc23)=NC(=C4O)C(O)=O)=O | InChi: | InChI=1S/C21H19N3O6/c25-16(11-30-15-9-3-6-12-5-1-2-7-13(12)15)24-10-4-8-14(24)19-22-17(21(28)29)18(26)20(27)23-19/h1-3,5-7,9,14,26H,4,8,10-11H2,(H,28,29)(H,22,23,27)/t14-/m0/s1 | 別名: | SRI-29789 | 定義日: | 2017-07-11 | 最終更新日: | 2020-06-17 | 公開日: | 2018-01-03 | 識別子(ID): | 5-hydroxy-2-[(2S)-1-{[(naphthalen-1-yl)oxy]acetyl}pyrrolidin-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid |
|
| MVD | 表記: | 2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3 | 組成式: | C28 H46 O3 | SMILES: | OC3C(C(=C/C=C1CCCC2(C)C(C(C)CCCC(O)(C)C)CCC12)CC(O)C3C)=C | InChi: | InChI=1S/C28H46O3/c1-18(9-7-15-27(4,5)31)23-13-14-24-21(10-8-16-28(23,24)6)11-12-22-17-25(29)20(3)26(30)19(22)2/h11-12,18,20,23-26,29-31H,2,7-10,13-17H2,1,3-6H3/b21-11+,22-12-/t18-,20+,23-,24+,25-,26-,28-/m1/s1 | 別名: | 9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL,2-METHYL-,(1A,2A,3B,5Z,7E) | 定義日: | 2006-06-20 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1S,2S,3R,5Z,7E,14beta,17alpha)-2-methyl-9,10-secocholesta-5,7,10-triene-1,3,25-triol |
|
| MVL | 表記: | (5R,6R,7S,8R)-5-(HYDROXYMETHYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | 組成式: | C8 H12 N2 O4 | SMILES: | n1ccn2c1C(O)C(O)C(O)C2CO | InChi: | InChI=1S/C8H12N2O4/c11-3-4-5(12)6(13)7(14)8-9-1-2-10(4)8/h1-2,4-7,11-14H,3H2/t4-,5-,6+,7+/m1/s1 | 別名: | Mannoimidazole | 定義日: | 2008-01-25 | 最終更新日: | 2020-06-17 | 識別子(ID): | (5R,6R,7S,8R)-5-(hydroxymethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6,7,8-triol |
|
| MWP | 表記: | 1-benzothiophen-6-amine 1,1-dioxide | 組成式: | C8 H7 N O2 S | SMILES: | O=S2(=O)c1cc(ccc1C=C2)N | InChi: | InChI=1S/C8H7NO2S/c9-7-2-1-6-3-4-12(10,11)8(6)5-7/h1-5H,9H2 | 別名: | 6-amino-benzothiophene-1,1-dione | 定義日: | 2012-03-28 | 最終更新日: | 2020-06-17 | 公開日: | 2013-01-25 | 識別子(ID): | 1-benzothiophen-6-amine 1,1-dioxide |
|
| MXM | 表記: | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide | 組成式: | C14 H13 N3 O4 S2 | SMILES: | O=C(Nc1ncc(s1)C)C3=C(O)c2ccccc2S(=O)(=O)N3C | InChi: | InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19) | 別名: | Meloxicam | 定義日: | 2013-08-09 | 最終更新日: | 2020-06-17 | 公開日: | 2014-01-22 | 識別子(ID): | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
|
| MXN | 表記: | (2R)-hydroxy(phenyl)ethanenitrile | 組成式: | C8 H7 N O | SMILES: | N#CC(O)c1ccccc1 | InChi: | InChI=1S/C8H7NO/c9-6-8(10)7-4-2-1-3-5-7/h1-5,8,10H/t8-/m0/s1 | 別名: | (R)-mandelonitrile | 定義日: | 2009-02-26 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2R)-hydroxy(phenyl)ethanenitrile |
|
| MXP | 表記: | Myxopyronin B | 組成式: | C23 H31 N O6 | SMILES: | O=C(C1=C(O)C=C(OC1=O)CCCC=CNC(=O)OC)C(=CC=C(/C)CCCC)C | InChi: | InChI=1S/C23H31NO6/c1-5-6-10-16(2)12-13-17(3)21(26)20-19(25)15-18(30-22(20)27)11-8-7-9-14-24-23(28)29-4/h9,12-15,25H,5-8,10-11H2,1-4H3,(H,24,28)/b14-9+,16-12+,17-13+ | 別名: | methyl [(1E)-5-{3-[(2E,4E)-2,5-dimethylnona-2,4-dienoyl]-4-hydroxy-2-oxo-2H-pyran-6-yl}pent-1-en-1-yl]carbamate | 定義日: | 2008-10-16 | 最終更新日: | 2020-06-17 | 識別子(ID): | methyl [(1E)-5-{3-[(2E,4E)-2,5-dimethylnona-2,4-dienoyl]-4-hydroxy-2-oxo-2H-pyran-6-yl}pent-1-en-1-yl]carbamate |
|
| MYC | 表記: | 3,5,7-TRIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE | 組成式: | C15 H10 O8 | SMILES: | O=C1c3c(OC(=C1O)c2cc(O)c(O)c(O)c2)cc(O)cc3O | InChi: | InChI=1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H | 別名: | 2-(3,4,5-TRIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-4H-1-BENZOPYRAN-4-ONE | 定義日: | 2000-10-04 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one |
|
| MYF | 表記: | 5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE | 組成式: | C15 H10 O7 | SMILES: | O=C1c3c(OC(=C1)c2cc(O)c(O)c(O)c2)cc(O)cc3O | InChi: | InChI=1S/C15H10O7/c16-7-3-8(17)14-9(18)5-12(22-13(14)4-7)6-1-10(19)15(21)11(20)2-6/h1-5,16-17,19-21H | 別名: | 2-(3,4,5-TRIHYDROXYPHENYL)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE | 定義日: | 2006-12-22 | 最終更新日: | 2020-06-17 | 識別子(ID): | 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one |
|
| MYU | 表記: | 3,5,6,7-TETRAHYDROXY-2-(3,4-DIHYDROXYPHENYL)-4H-CHROMEN-4-ONE | 組成式: | C15 H10 O8 | SMILES: | O=C1c3c(O)c(O)c(O)cc3OC(=C1O)c2ccc(O)c(O)c2 | InChi: | InChI=1S/C15H10O8/c16-6-2-1-5(3-7(6)17)15-14(22)13(21)10-9(23-15)4-8(18)11(19)12(10)20/h1-4,16-20,22H | 別名: | 2-(3,4-DIHYDROXYPHENYL)-3,5,6,7-TETRAHYDROXY-4H-1-BENZOPYRAN-4-ONE | 定義日: | 2007-07-10 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4H-chromen-4-one |
|
| MZ0 | 表記: | 1H-imidazol-5-ylmethanol | 組成式: | C4 H6 N2 O | SMILES: | OCc1cncn1 | InChi: | InChI=1S/C4H6N2O/c7-2-4-1-5-3-6-4/h1,3,7H,2H2,(H,5,6) | 別名: | 4(5)-(hydroxymethyl)imidazole | 定義日: | 2012-10-26 | 最終更新日: | 2020-06-17 | 公開日: | 2013-10-23 | 識別子(ID): | 1H-imidazol-5-ylmethanol |
|
| MZJ | 表記: | 1-[4-({[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino}methyl)piperidin-1-yl]prop-2-en-1-one | 組成式: | C25 H27 N5 O2 | SMILES: | n1c(c(c(nc1)N)c2ccc(cc2)Oc3ccccc3)NCC4CCN(C(=O)[C@H]=C)CC4 | InChi: | InChI=1S/C25H27N5O2/c1-2-22(31)30-14-12-18(13-15-30)16-27-25-23(24(26)28-17-29-25)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-11,17-18H,1,12-16H2,(H3,26,27,28,29) | 別名: | Evobrutinib | 定義日: | 2019-04-24 | 最終更新日: | 2020-06-17 | 公開日: | 2019-08-14 | 識別子(ID): | 1-[4-({[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino}methyl)piperidin-1-yl]prop-2-en-1-one |
|